Predictive value of antinuclear antibodies in autoimmune diseases classified by clinical criteria: Analytical study in a specialized health institute, one year follow-up

Results in Immunology

Volumn 5, Issue , 2015, Pages 13-22

  Soto, María Elena ^a   Hernández Becerril, Nidia ^a   Perez Chiney, Ada Claudia ^a   Hernández Rizo, Alfredo ^a   Telich Tarriba, José Eduardo ^b   Juárez Orozco, Luis Eduardo ^c   Melendez, Gabriela ^a   Bojalil, Rafael ^a,d  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b UNIVERSIDAD PANAMERICANA   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^d DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

Author keywords

Antinuclear antibodies; Clinical criteria; Generalized rheumatic disease; Predictive value

Indexed keywords

ANTINUCLEAR ANTIBODY;

ADULT; ANCA ASSOCIATED VASCULITIS; AORTA ARCH SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; CARDIOMYOPATHY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HUMAN; IMMUNOASSAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SUPRAVENTRICULAR TACHYCARDIA; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC RHEUMATIC DISEASE; SYSTEMIC SCLEROSIS;

EID: 84932632825     PISSN: None     EISSN: 22112839     Source Type: Journal    
DOI: 10.1016/j.rinim.2013.10.003     Document Type: Article

References (64)

1. Hernandez Ramirez D.F., Cabiedes J. Immunological techniques that support the diagnosis of the autoimmune diseases. Reumatol. Clin. 2010, 6(3):173-177.
2. Cabiedes J., Nunez-Alvarez C.A. Antinuclear antibodies. Reumatol. Clin. 2010, 6(4):224-230.
3. Briolay J., Gioud M., Monier J.C., et al. Antinuclear antibodies detected by indirect immunofluorescence on HEp2 cells and by immunoblotting in patients with systemic sclerosis. Autoimmunity 1989, 2(2):165-176.
4. Sheldon J. Laboratory testing in autoimmune rheumatic diseases. Best Pract. Res. Clin. Rheumatol. 2004, 18(3):249-269.
5. Binder S.R. Autoantibody detection using multiplex technologies. Lupus 2006, 15(7):412-421.
6. McBride J.D., Gabriel F.G., Fordham J., et al. Screening autoantibody profiles in systemic rheumatic disease with a diagnostic protein microarray that uses a filtration-assisted nanodot array luminometric immunoassay (NALIA). Clin. Chem. 2008, 54(5):883-890.
7. Slater C.A., Davis R.B., Shmerling R.H. Antinuclear antibody testing. A study of clinical utility. Arch. Intern. Med. 1996, 156(13):1421-1425.
8. Kiuttu J., Hartikainen A.L., Makitalo R., Ruuska P. The outcome of pregnancy in antinuclear antibody-positive women. Gynecol. Obstet. Invest. 1994, 37(3):160-163.
9. Kulthanan K., Jiamton S., Omcharoen V., Linpiyawan R., Ruangpeerakul J., Sivayathorn A. Autoimmune and rheumatic manifestations and antinuclear antibody study in HIV-infected Thai patients. Int. J. Dermatol. 2002, 41(7):417-422.
10. Martinez-Cordero E., Bessudo-Babani A., Trevino-Perez S.C., Teran L., Selman M., Martinez-Miranda E. Circulating autoantibodies in patients with pigeon breeder's disease. Allergol. Immunopathol. 1989, 17(1):1-6.
11. Ward M.M. Laboratory testing for systemic rheumatic diseases. Postgrad. Med. 1998, 103(2):93-100.
12. Xavier R.M., Yamauchi Y., Nakamura M., et al. Antinuclear antibodies in healthy aging people: a prospective study. Mech. Ageing Dev. 1995, 78(2):145-154.
13. Satoh M., Chan E.K., Sobel E.S., et al. Clinical implication of autoantibodies in patients with systemic rheumatic diseases. Expert Rev. Clin. Immunol. 2007, 3(5):721-738.
14. Abu-Shakra M., Shoenfeld Y. Natural hidden autoantibodies. Isr. Med. Assoc. J. 2007, 9(10):748-749.
15. Fernandez-Madrid F., Mattioli M. Antinuclear antibodies (ANA): immunologic and clinical significance. Semin. Arthritis Rheumatol. 1976, 6(2):83-124.
16. Marin G.G., Cardiel M.H., Cornejo H., Viveros M.E. Prevalence of antinuclear antibodies in 3 groups of healthy individuals: blood donors, hospital personnel, and relatives of patients with autoimmune diseases. J. Clin. Rheumatol. 2009, 15(7):325-329.
17. George J., Gilburd B., Shoenfeld Y. The emerging concept of pathogenic natural autoantibodies. Hum. Antibodies 1997, 8(2):70-75.
18. Baumgarth N., Tung J.W., Herzenberg L.A. Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion. Semin. Immunopathol. 2005, 26(4):347-362.
19. Hamaguchi Y. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis. J. Dermatol. 2010, 37(1):42-53.
20. Verstegen G., Duyck M.C., Meeus P., Ravelingien I., De V.K. Detection and identification of antinuclear antibodies (ANA) in a large community hospital. Acta Clin. Belg. 2009, 64(4):317-323.
21. Hayashi N., Koshiba M., Nishimura K., et al. Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period. Mod. Rheumatol. 2008, 18(2):153-160.
22. Sebastian W., Roy A., Kini U., Mullick S. Correlation of antinuclear antibody immunofluorescence patterns with immune profile using line immunoassay in the Indian scenario. Indian J. Pathol. Microbiol. 2010, 53(3):427-432.
23. Lora P.S., Laurino C.C., Becker B.S., Monticielo O.A., Brenol J.C., Xavier R.M. Clinical diagnostic performance of different methods for the detection of antibodies to extractable nuclear antigens in connective tissue diseases: a cohort study. Clin. Lab 2011, 57(7-8):625-629.
24. Pittock S.J., Lennon V.A., de S.J., et al. Neuromyelitis optica and non organ-specific autoimmunity. Arch. Neurol. 2008, 65(1):78-83.
25. Buskila D., Berezin M., Gur H., et al. Autoantibody profile in the sera of women with hyperprolactinemia. J. Autoimmun. 1995, 8(3):415-424.
26. Falanga V., Medsger T.A., Reichlin M. Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea. Arch. Dermatol. 1987, 123(3):350-353.
27. Gripenberg M., Helve T., Kurki P. Profiles of antibodies to histones, DNA and IgG in patients with systemic rheumatic diseases determined by ELISA. J. Rheumatol. 1985, 12(5):934-939.
28. Krawiec P., Batko B., Skura A., et al. Difficulties in differential diagnosis of Sjogren's syndrome and systemic lupus erythematosus. Przegl. Lek. 2006, 63(5):278-283.
29. Warner N.Z., Greidinger E.L. Patients with antibodies to both PmScl and dsDNA. J. Rheumatol. 2004, 31(11):2169-2174.
30. Gulko P.S., Reveille J.D., Koopman W.J., Burgard S.L., Bartolucci A.A., Alarcon G.S. Survival impact of autoantibodies in systemic lupus erythematosus. J. Rheumatol. 1994, 21(2):224-228.
31. Provost T.T., Watson R. Antinuclear antibodies in systemic lupus erythematosus. Immunol. Ser. 1989, 46:333-357.
32. Tan E.M. Special antibodies for the study of systemic lupus erythematosus: an analysis. Arthritis Rheumatol. 1982, 25(7):753-756.
33. Thompson D., Juby A., Davis P. The clinical significance of autoantibody profiles in patients with systemic lupus erythematosus. Lupus 1993, 2(1):15-19.
34. Liang K.P., Kremers H.M., Crowson C.S., et al. Autoantibodies and the risk of cardiovascular events. J. Rheumatol. 2009, 36(11):2462-2469.
35. Tonietti G., Oldstone M.B., Dixon F.J. The effect of induced chronic viral infections on the immunologic diseases of New Zealand mice. J. Exp. Med. 1970, 132(1):89-109.
36. Simmons-O'Brien E., Chen S., Watson R., et al. One hundred anti-Ro (SS-A) antibody positive patients: a 10-year follow-up. Medicine 1995, 74(3):109-130.
37. Lussiez V., Combe B., Graafland H., Rucheton M., Sany J. Anti-Sm and anti-RNP antibodies detected by immunoblotting in disseminated lupus erythematosus. Rev. Rhum. Mal. Osteoartic. 1989, 56(1):35-38.
38. Tan E.M., Chan E.K., Sullivan K.F., Rubin R.L. Antinuclear antibodies (ANAs): diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity. Clin. Immunol. Immunopathol. 1988, 47(2):121-141.
39. Malleson P.N., Sailer M., Mackinnon M.J. Usefulness of antinuclear antibody testing to screen for rheumatic diseases. Arch. Dis. Child 1997, 77(4):299-304.
40. Bernstein R.M., Steigerwald J.C., Tan E.M. Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis. Clin. Exp. Immunol. 1982, 48(1):43-51.
41. Andrade L.E., Chan E.K., Peebles C.L., Tan E.M. Two major autoantigen-antibody systems of the mitotic spindle apparatus. Arthritis Rheumatol. 1996, 39(10):1643-1653.
42. Mozo L., Gutierrez C., Gomez J. Antibodies to mitotic spindle apparatus: clinical significance of NuMA and HsEg5 autoantibodies. J. Clin. Immunol. 2008, 28(4):285-290.
43. Bonaci-Nikolic B., Andrejevic S., Bukilica M., Urosevic I., Nikolic M. Autoantibodies to mitotic apparatus: association with other autoantibodies and their clinical significance. J. Clin. Immunol. 2006, 26(5):438-446.
44. Grypiotis P., Ruffatti A., Tonello M., et al. Clinical significance of fluoroscopic patterns specific for the mitotic spindle in patients with rheumatic diseases. Reumatismo 2002, 54(3):232-237.
45. Mahler M., Miyachi K., Peebles C., Fritzler M.J. The clinical significance of autoantibodies to the proliferating cell nuclear antigen (PCNA). Autoimmun. Rev. 2012.
46. Karassa F.B., Afeltra A., Ambrozic A., et al. Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis. Arthritis Rheumatol. 2006, 54(1):312-324.
47. Nozawa K., Fritzler M.J., Chan E.K. Unique and shared features of Golgi complex autoantigens. Autoimmun. Rev. 2005, 4(1):35-41.
48. Kuwana M., Kaburaki J., Mimori T., Tojo T., Homma M. Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis. J. Clin. Invest. 1993, 91(4):1399-1404.
49. Satoh M., Ajmani A.K., Ogasawara T., et al. Autoantibodies to RNA polymerase II are common in systemic lupus erythematosus and overlap syndrome. Specific recognition of the phosphorylated (IIO) form by a subset of human sera. J. Clin. Invest. 1994, 94(5):1981-1989.
50. Steen V.D. The many faces of scleroderma. Rheum. Dis. Clin. N. Am. 2008, 34(1):1-15.
51. Tampoia M., Brescia V., Fontana A., Zucano A., Morrone L.F., Pansini N. Application of a combined protocol for rational request and utilization of antibody assays improves clinical diagnostic efficacy in autoimmune rheumatic disease. Arch. Pathol. Lab Med. 2007, 131(1):112-116.
52. Damoiseaux J.G., Tervaert J.W. From ANA to ENA: how to proceed?. Autoimmun. Rev. 2006, 5(1):10-17.
53. Tozzoli R., Bizzaro N., Tonutti E., et al. Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am. J. Clin. Pathol. 2002, 117(2):316-324.
54. Solomon D.H., Kavanaugh A.J., Schur P.H. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheumatol. 2002, 47(4):434-444.
55. van W.C., Naylor C.D. Do we know what inappropriate laboratory utilization is? A systematic review of laboratory clinical audits. J. Am. Med. Assoc. 1998, 280(6):550-558.
56. Solomon D.H., Hashimoto H., Daltroy L., Liang M.H. Techniques to improve physicians' use of diagnostic tests: a new conceptual framework. J. Am. Med. Assoc. 1998, 280(23):2020-2027.
57. Ahlin E., Mathsson L., Eloranta M.L., et al. Autoantibodies associated with RNA are more enriched than anti-dsDNA antibodies in circulating immune complexes in SLE. Lupus 2012.
58. Koivula M.K., Heliovaara M., Rissanen H., et al. Antibodies binding to citrullinated telopeptides of type I and type II collagens and to mutated citrullinated vimentin synergistically predict the development of seropositive rheumatoid arthritis. Ann. Rheum. Dis. 2012.
59. Van den B.K., Vercammen M., Regenass S., et al. Betaine homocysteine methyl transferase 1, a novel auto-antigen associated with anti-Golgi immune reactivity. Clin. Chim. Acta 2012, 413(1-2):105-108.
60. Hung W.T., Chen Y.M., Lan J.L., et al. Antinucleosome antibodies as a potential biomarker for the evaluation of renal pathological activity in patients with proliferative lupus nephritis. Lupus 2011, 20(13):1404-1410.
61. Granito A., Muratori P., Quarneti C., Pappas G., Cicola R., Muratori L. Antinuclear antibodies as ancillary markers in primary biliary cirrhosis. Expert Rev. Mol. Diagn. 2012, 12(1):65-74.
62. Hudson M., Mahler M., Pope J., et al. Clinical correlates of CENP-A and CENP-B antibodies in a large cohort of patients with systemic sclerosis. J. Rheumatol. 2012.
63. Bonaguri C., Melegari A., Ballabio A., et al. Italian multicentre study for application of a diagnostic algorithm in autoantibody testing for autoimmune rheumatic disease: conclusive results. Autoimmun. Rev. 2011, 11(1):1-5.
64. Bizzaro N., Tozzoli R., Tonutti E., et al. Variability between methods to determine ANA, anti-dsDNA and anti-ENA autoantibodies: a collaborative study with the biomedical industry. J. Immunol. Methods 1998, 219(1-2):99-107.